Τίτλος:
Editorial: The new trial EMPAREG-outcomes in type 2 diabetes: “and death shall have no dominion”?
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Συγγραφείς:
Papanas, N.
Tsioufis, C.
Maltezos, E.S.
Περιοδικό:
Current Vascular Pharmacology
Εκδότης:
Bentham Science Publishers B.V.
Λέξεις-κλειδιά:
alogliptin; empagliflozin; glucagon; hemoglobin A1c; high density lipoprotein cholesterol; insulin glargine; lixisenatide; low density lipoprotein cholesterol; saxagliptin; sitagliptin; antidiabetic agent; benzhydryl derivative; glucoside, body weight; cardiovascular mortality; cerebrovascular accident; clinical trial (topic); Editorial; glycemic control; heart failure; heart infarction; hospitalization; human; non insulin dependent diabetes mellitus; outcome assessment; systolic blood pressure; transient ischemic attack; waist circumference; cardiovascular disease; complication; mortality; non insulin dependent diabetes mellitus, Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypoglycemic Agents
DOI:
10.2174/1570161114999160229142200
